#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4074	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2412	348.7	0	.	n	.	0	C451T	SNP	451	451	C	827	827	T	450	T,C	252,81	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4074	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2412	348.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1560	1560	C	516	C,A	373,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4074	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2412	348.7	0	HET	.	.	.	C1450T,A	.	1450	1450	C	1826	1826	C	493	C,T,A	264,70,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4074	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2412	348.7	0	HET	.	.	.	C207T	.	207	207	C	583	583	C	378	C,T	229,61	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7864	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4150	387.3	0	.	n	.	0	T695C	SNP	695	695	T	1364	1364	C	559	C,A,G	385,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7864	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4150	387.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2640	2640	C	482	C,T	335,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7864	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4150	387.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2714	2714	A	548	A	379	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7864	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4150	387.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3266	3266	C	592	C	423	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	316	folP	855	855	100.0	folP.l6.c4.ctg.1	2039	33.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1334	1336	AGC	51;51;51	A;G;C	38;38;38	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	872	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3895	46.8	1	SNP	p	S91F	1	.	.	271	273	TTC	922	924	TTC	65;65;65	T;T;C	47;45;47	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	872	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3895	46.8	1	SNP	p	G95N	0	.	.	283	285	GGC	934	936	GGC	69;74;75	G;G;C	50;53;53	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	872	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3895	46.8	1	SNP	p	D95G	1	.	.	283	285	GGC	934	936	GGC	69;74;75	G;G;C	50;53;53	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	266	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1425	39.6	1	SNP	p	G45D	0	.	.	133	135	GGC	600	602	GGC	89;89;89	G;G;C	60;61;61	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	230	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1467	31.5	0	.	n	.	0	A197.	DEL	197	197	A	1058	1058	A	82	A	62	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	826	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3178	53.1	1	SNP	p	D86N	0	.	.	256	258	GAC	636	638	GAC	68;68;69	G;A;C	47;47;47	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	826	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3178	53.1	1	SNP	p	R87I	0	.	.	259	261	CGT	639	641	CGT	68;68;67	C;G;T	48;49;48	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	826	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3178	53.1	1	SNP	p	R87W	0	.	.	259	261	CGT	639	641	CGT	68;68;67	C;G;T	48;49;48	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	826	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3178	53.1	1	SNP	p	S87R	1	.	.	259	261	CGT	639	641	CGT	68;68;67	C;G;T	48;49;48	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	826	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3178	53.1	1	SNP	p	S88P	0	.	.	262	264	TCC	642	644	TCC	67;67;67	T;C,T;C	47;48,1;46	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	704	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2980	49.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1662	1664	GGC	37;37;39	G;G;C	28;24;25	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	804	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2825	58.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1716	1718	GCC	112;113;113	G,T;C;C	82,1;83;82	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	804	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2825	58.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1719	1721	ATG	113;116;116	A;T;G	83;82;82	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	804	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2825	58.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1731	1733	ACC	117;117;117	A;C,A;C,A	83;83,1;83,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	804	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2825	58.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1731	1733	ACC	117;117;117	A;C,A;C,A	83;83,1;83,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	804	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2825	58.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2232	2234	ACC	88;88;86	A;C;C	64;64;64	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	804	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2825	58.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2286	2288	GCG	75;73;73	G;C,G;G,T	57;50,1;51,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	804	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2825	58.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2286	2288	GCG	75;73;73	G;C,G;G,T	57;50,1;51,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	804	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2825	58.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2409	2411	GGT	64;64;61	G,T;G,T;T	46,1;45,1;46	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	804	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2825	58.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2418	2420	AGC	56;56;55	A,G;G,A;C,A	34,1;37,1;37,2	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	804	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2825	58.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2436	2438	CCG	38;37;37	C,G;C,G;G,T,C	21,3;26,1;25,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1484	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3553	83.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1808	1810	CCG	78;77;79	C,G;C,T;G,C	58,2;59,1;47,5	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	320	porA	1146	1146	99.91	porA.l15.c4.ctg.2	1942	32.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	707	707	C	34	C	22	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	I45V	NONSYN	133	135	ATT	447	449	GTT	64;64;64	G;T,G;T	50;49,1;50	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	I75V	NONSYN	223	225	ATT	537	539	GTT	66;66;65	G;T,G;T	49;44,1;47	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	S89T	NONSYN	265	267	AGC	579	581	ACC	69;71;68	A,C;C;C	48,1;50;49	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	I98V	NONSYN	292	294	ATC	606	608	GTC	66;65;60	G;T;C	45;45;43	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	A109V	NONSYN	325	327	GCC	639	641	GTC	51;51;51	G;T;C	37;33;36	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	705	707	TAT	58;59;59	T;A;T	45;46;42	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	N134E	NONSYN	400	402	AAT	714	716	GAG	63;64;64	G;A;G	46;49;48	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	V135L	NONSYN	403	405	GTG	717	719	CTT	64;65;65	C;T;T	48;49;49	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	G140K	NONSYN	418	420	GGA	732	734	AAA	67;67;67	A;A;A	50;50;50	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	Q143G	NONSYN	427	429	CAA	741	743	GGA	67;71;71	G;G;A	49;53;51	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	518	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1735	60.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	765	767	GCA	74;74;73	G;C;A	55;54;54	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2096	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4836	90.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	174	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1666	22.4	1	SNP	p	V57M	1	.	.	169	171	ATG	668	670	ATG	52;51;52	A;T;G	37;36;37	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
